These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

762 related items for PubMed ID: 17126520

  • 1. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease.
    Kedora J, Hohmann S, Garrett W, Munschaur C, Theune B, Gable D.
    J Vasc Surg; 2007 Jan; 45(1):10-6; discussion 16. PubMed ID: 17126520
    [Abstract] [Full Text] [Related]

  • 2. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K, Gable D, Hohman S, Pearl G, Theune B.
    J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
    [Abstract] [Full Text] [Related]

  • 3. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K, Gable D, Pearl G, Theune B, Black S.
    J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
    [Abstract] [Full Text] [Related]

  • 4. Management of flush superficial femoral artery occlusions with combined open femoral endarterectomy and endovascular femoral-popliteal angioplasty and stent-grafting.
    Hayes DJ, Dougherty MJ, Calligaro KD.
    Ann Vasc Surg; 2011 May; 25(4):559.e19-23. PubMed ID: 21549939
    [Abstract] [Full Text] [Related]

  • 5. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass.
    Lumsden AB, Morrissey NJ, Comparison of Safety and Primary Patency Between the FUSION BIOLINE Heparin-Coated Vascular Graft and EXXCEL Soft ePTFE (FINEST) Trial Co-investigators.
    J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929
    [Abstract] [Full Text] [Related]

  • 6. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease.
    Geraghty PJ, Mewissen MW, Jaff MR, Ansel GM, VIBRANT Investigators.
    J Vasc Surg; 2013 Aug; 58(2):386-95.e4. PubMed ID: 23676191
    [Abstract] [Full Text] [Related]

  • 7. A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.
    Rychlik IJ, Davey P, Murphy J, O'Donnell ME.
    J Vasc Surg; 2014 Aug; 60(2):506-15. PubMed ID: 24973288
    [Abstract] [Full Text] [Related]

  • 8. Endovascular treatment of long lesions of the superficial femoral artery: results from a multicenter registry of a spiral, covered polytetrafluoroethylene stent.
    Lenti M, Cieri E, De Rango P, Pozzilli P, Coscarella C, Bertoglio C, Troiani R, Cao P.
    J Vasc Surg; 2007 Jan; 45(1):32-9. PubMed ID: 17210380
    [Abstract] [Full Text] [Related]

  • 9. Outcome of the FUSION vascular graft for above-knee femoropopliteal bypass.
    Assadian A, Eckstein HH, Peripheral Bypass Grafting: Prospective Evaluation of FUSION Vascular Graft for Above Knee Targets (PERFECTION) Study Group.
    J Vasc Surg; 2015 Mar; 61(3):713-9.e1. PubMed ID: 25498193
    [Abstract] [Full Text] [Related]

  • 10. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
    Lammer J, Zeller T, Hausegger KA, Schaefer PJ, Gschwendtner M, Mueller-Huelsbeck S, Rand T, Funovics M, Wolf F, Rastan A, Gschwandtner M, Puchner S, Ristl R, Schoder M.
    J Am Coll Cardiol; 2013 Oct 08; 62(15):1320-7. PubMed ID: 23831445
    [Abstract] [Full Text] [Related]

  • 11. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial.
    Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Jaff MR, RESILIENT Investigators.
    Circ Cardiovasc Interv; 2010 Jun 01; 3(3):267-76. PubMed ID: 20484101
    [Abstract] [Full Text] [Related]

  • 12. Midterm results of a precuffed expanded polytetrafluoroethylene graft for above knee femoropopliteal bypass in a multicenter study.
    Rückert RI, Tsilimparis N, Lobenstein B, Witte J, Seip G, Storck M.
    J Vasc Surg; 2009 May 01; 49(5):1203-9.e3. PubMed ID: 19394549
    [Abstract] [Full Text] [Related]

  • 13. Endovascular exclusion of popliteal artery aneurysms with expanded polytetrafluoroethylene stent-grafts: early results.
    Rajasinghe HA, Tzilinis A, Keller T, Schafer J, Urrea S.
    Vasc Endovascular Surg; 2009 May 01; 40(6):460-6. PubMed ID: 17202092
    [Abstract] [Full Text] [Related]

  • 14. Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases.
    Ascher E, Marks NA, Hingorani AP, Schutzer RW, Mutyala M.
    J Vasc Surg; 2006 Dec 01; 44(6):1230-7; discussion 1237-8. PubMed ID: 17055689
    [Abstract] [Full Text] [Related]

  • 15. Heparin-bonded expanded polytetrafluoroethylene femoropopliteal bypass grafts outperform expanded polytetrafluoroethylene grafts without heparin in a long-term comparison.
    Samson RH, Morales R, Showalter DP, Lepore MR, Nair DG.
    J Vasc Surg; 2016 Sep 01; 64(3):638-47. PubMed ID: 27139782
    [Abstract] [Full Text] [Related]

  • 16. Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease.
    Ricco JB, Probst H, French University Surgeons Association.
    J Vasc Surg; 2008 Jan 01; 47(1):45-53; discussion 53-4. PubMed ID: 17997269
    [Abstract] [Full Text] [Related]

  • 17. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB, Lotina SI, Kostić DM, Cinara II, Cvetković SD, Stojanov PL, Velimirović DB, Marković MM, Pejkić SA, Vukotić AM.
    Srp Arh Celok Lek; 1997 Jan 01; 125(1-2):24-35. PubMed ID: 17974352
    [Abstract] [Full Text] [Related]

  • 18. Midterm results of autologous saphenous vein and ePTFE pre-cuffed bypass surgery in peripheral arterial occlusive disease.
    Donker JM, Ho GH, Te Slaa A, de Groot HG, van der Waal JC, Veen EJ, van der Laan L.
    Vasc Endovascular Surg; 2011 Oct 01; 45(7):598-603. PubMed ID: 21757494
    [Abstract] [Full Text] [Related]

  • 19. Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial.
    Zeller T, Peeters P, Bosiers M, Lammer J, Brechtel K, Scheinert D, Rastan A, Noory E, Beschorner U.
    J Endovasc Ther; 2014 Dec 01; 21(6):765-74. PubMed ID: 25453876
    [Abstract] [Full Text] [Related]

  • 20. Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results.
    Daenens K, Schepers S, Fourneau I, Houthoofd S, Nevelsteen A.
    J Vasc Surg; 2009 May 01; 49(5):1210-6. PubMed ID: 19394550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.